Reflections on Dubai

Dubai once again proved to be a global hub for innovation as industry leaders, researchers and healthcare professionals gathered for a dynamic and forward-looking congress. Among the standout highlights was the presence of Frontier Diagnostics; showcasing cutting-edge advancements that are shaping the future of medical diagnostics.

A Glimpse into the Future of Diagnostics
Frontier Diagnostics brought an inspiring vision to life- demonstrating how next generation liquid biopsy platforms and advanced diagnostic tools are transforming patient care. Their technology emphasises precision, speed and accessibility, which may help healthcare providers to detect and monitor diseases with unprecedented accuracy.

The exhibition space captured attention with bold visuals and clear messaging; diagnostics is evolving, and the future is already here.

Innovation that empowers
At the heart of Frontier’s showcase was a commitment to empowering clinicians and researchers. The solutions are designed to;

Simplify complex diagnostic workflows
Deliver faster, more reliable results
Enhance patient outcomes through early detection.

This aligns perfectly with the global shift toward personalised medicine- where treatments are tailored to individual patients based on precise data.

A Collaborative Spirit
The Congress wasn’t just about technology- it was about connection and collaboration. Attendees from around the world engaged in meaningful conversations, exchanging ideas and exploring partnerships that will drive the industry forward.

Frontier Diagnostics revelled in the collaborative spirit, welcoming discussions and inspiring innovation across borders.

As the congress concluded, one thing is clear – the future of diagnostics is bright. With pioneering technology, we can expect continued breakthroughs which will redefine how diseases are detected, monitored and treated.

Tackling CTCs’ reputation head-on

Walk into almost any breast cancer conference and mention CTCs- Circulating Tumour Cells- and you’ll sense the discomfort immediately. The CTC diagnostics market has long been dogged by the limitations of early technologies: detecting only a handful of cells, then doing little more than counting them.That reputation was further damaged by companies marketing tests directly to some of the most vulnerable people – those worried they might have breast cancer.

That era is now over.

We’re no longer talking about identifying and counting a few isolated circulating tumour cells. Today’s breakthrough technology can identify thousands of cells, repeatedly, with consistent accuracy. More importantly, it’s no longer just about quantity. It’s about understanding the biology of these cells- their characteristics, behaviour, and evolution over time.

This transforms what CTC testing can achieve. It supports early detection through reliable, high-volume identification, supports truly personalised treatment decisions, and allows for ongoing monitoring through regular, minimally invasive tests. Crucially, it also opens the door to relapse monitoring, with the potential to identify emerging tumours- or even suspicious cell clusters- up to 18 months earlier than traditional screening methods.

CTCs are no longer a dirty word. They’re becoming a powerful tool in the future of breast cancer detection, treatment and long-term care.

The case for CTC innovation – the breast cancer stats!

Breast cancer represents one of the most significant and durable opportunities in the global oncology diagnostics sector. Breast cancer is the most common cancer in women around the world, with around 2.3 million new cases recorded in 2022, according to data from WHO’s Global Cancer Observatory (GLOBOCAN). By 2050, new cases and deaths are projected to increase by 38% and 68% respectively, disproportionately impacting lower income countries.

 

The global breast cancer diagnostics market reflects this urgency at scale.  The market was valued at approximately $4,42 billion in 2023 and is forecast to reach $8.27 billion by 2032, growing at a CAGR of around 7.2% (Zion Market Research, 2024). This growth is underpinned by structural changes: ageing populations, rising global incidence, broadening screening mandates and sustained healthcare investment across both developed and emerging markets. While North America dominates, Asia-Pacific is projected to expand at the fastest rate over the coming decade.

Yet market size alone does not define the opportunity. The more compelling story lies in the inadequacy of existing solutions. Tissue biopsy – still the diagnostic gold standard – is invasive, slow , costly and unable to capture the dynamic, evolving nature of tumour biology. Mammography and imaging represent the largest market segment, (51% of revenue in 2025) – yet carry well-documented limitations, not least in those with dense breast tissue. The result is a diagnostics landscape that is large, growing and ripe for innovation.

Blood-based tests represent the fastest growing segment of breast cancer diagnostics. Liquid biopsy, and specifically circulating tumour cell (CTC) technology, addresses the gaps in current care directly.

At Frontier Diagnostics, we are developing next generation CTC diagnostic platforms – designed for clinical scalability and commercial deployment. We are entering a market with proven demand and a clear unmet need, where previous CTC technology has stumbled but where Frontier Diagnostics is charting new territory and a radical improvement to the previous technology.

This convergence is where significant value is created.

World Cancer Day & the UK’s National Cancer Plan Launch

World Cancer Day, has been in the headlines this week – and here at Frontier Diagnostics – we’re united by a shared vision; to transform the landscape of diagnostics and care for all those affected by cancer. So we welcome the launch of the UK Government’s National Cancer Plan.

 

So what is a cancer plan/strategy and why does it matter?

The International Cancer Benchmarking Partnership (ICBP) has monitored cancer data across seven countries since the 90s when the UK and Denmark were bottom of the table. Since then, Denmark’s improvement has been remarkable – thanks to successive cancer plans – each targeting their weaker areas with focused targets, transparent monitoring, absolute patient focus and significant investment.

However, unlike Denmark, the UK has had a fragmented approach with Scotland, Wales and N. Ireland having strategies in place, but England relying on the NHS Long Term Plan (2019) – which wasn’t specific to cancer and was further derailed by COVID. So the UK has been lagging behind its European neighbours  in key measures; such as the five year cancer survival rates.

So what are the headlines and will it help those with breast cancer in the UK?

  • Three out of four patients diagnosed from 2025 will be cancer-free or living well after five years, (up from 60% currently) following record investment in the NHS – which is described as the fastest improvement in cancer outcomes this century!
  • The NHS will meet all cancer waiting time standards by 2029, with hundreds of thousands more patients treated within 62 days- a target which hasn’t been met since 2015.

Faster Diagnosis

  • The plan pushes for cancer to be diagnosed earlier and more quickly, which is crucial for breast cancer outcomes because earlier-stage detection improves survival.
  • It includes measures to speed up diagnostics and meet listing time standards by 2029, so women referred with suspected breast cancer symptoms should get faster scans and results.

Improving Screening Uptake

  • While breast screening is not a new policy in the plan, the strategy’s emphasis on boosting screening and reducing inequalities supports efforts to increase breast screening participation, especially in underserved communities.
  • Earlier detection via screening increases the chances of catching breast cancer when it’s most treatable.

More Personalised Treatment

  • Wider use of genomic and molecular testing supporting more tailored treatment decisions benefiting all breast cancer sub-types

Better Access to Specialist Care

  • Emphasis on specialist cancer centres, multidisciplinary teams and modern surgical techniques to improve consistency and quality of breast cancer treatment across England.

Improved Support for Life beyond Cancer

  • Recognition of the growing number of people living with and beyond breast cancer, with a focus on recovery, quality of life and long-term support.

Better Access to Clinical Trials

  • Plans to enable patients to search and sign up for clinical trials via the NHS app – tied into national databases.

The plan is not breast cancer specific, but its focus on speed, early diagnosis, innovation and equity addresses many of the issues that matter to people with breast cancer. And from a Frontier perspective; there is a huge opportunity for us to support the UK Government’s ambitious plan over the next few years with our potential for diagnostics, personalised treatment and monitoring for recurrence support.

Demystifying the fear of recurrence

– PART 3 OF OUR BREAST CANCER AWARENESS MONTH SERIES

So – you’ve already been unlucky and have been diagnosed with breast cancer once and managed to get through a treatment regime and beyond. Now people around you behave as if ‘everything’s back to normal”, yet for you, life will never be the same again and your inner monologue around any signs of it recurring can take over your life.

So how do you cope? Here’s what I’ve learned from living with it and being diagnosed a second time around.

  1. Be honest with yourself about how you feel – yes there will be times when you don’t want to think about it but acknowledging how you actually feel about it is the first critical step in actively managing your natural fears whilst managing to get on and enjoy your life. It’s normal to feel fear, it’s normal to feel your reactions to everyday aches and pains are OTT.
  2. Inform yourself – stay in control – understand your prognosis and what symptoms to look out for. You may feel better if you can rule out certain things and know they’re not related. Talk to your medical team so you know exactly what you should be looking out for and how to get in touch, should you need to do so. Remember it’s your body and you’re the expert who’s likely to notice any changes first. Don’t worry about feeling you’re making a fuss – it’s their job!
  3. Don’t be afraid of talking to people about it – family and friends can be very supportive but only if they know what you’re feeling and facing. You don’t have to do this alone. There are also really supportive online chatrooms and forums where you can talk to other women going through the same thing and share experiences.
  4. Remember that you know more now – think back to how little you may have known when you were first diagnosed with breast cancer. You’ve been through it and can use all that experience to help you now.
  5. Explore self-care – you’ve been through a lot and it is time to put yourself first and look after yourself – make time, explore whatever might work for you – there are a number of charities, which continue to offer complementary therapies to women who’ve been through breast cancer. Have a look at what might work for you.
  6. Explore coping strategies – what works for you? The one thing we all have is a greater understanding than most people of how precious life is. What will make you feel better? Try things. But know that it’s not you being a neurotic mess – this is normal and you’re not alone!

Supporting someone with a breast cancer diagnosis

3 THINGS NOT TO SAY AND WHAT YOU NEED TO SAY INSTEAD.

Being diagnosed with breast cancer is possibly one of the worst things which happen to anyone. And those around us, even our closest friends and family find it very hard to know what to do and what to say. This sometimes means they say the wrong thing, not because they’re deliberately trying to hurt us or be unhelpful – but because it’s so outside their own experience – often they’re looking at it from their own perspective and worrying about not being supportive.

Instead, if you have a close friend or family member who’s received a cancer diagnosis. Remember – it’s not about you – it’s about them and making sure they know you care.

1. Acknowledge that something dreadful has happened to them.
Number one thing not to say is– you’ll be fine! You don’t know that and it’s not helpful. Just acknowledge that it is hard by saying so. “That’s so awful/shit for you. I’m so sorry.”
Equally – I know you’ll get through this – you’re really strong – they might not be feeling strong and you need to support them in showing emotion if that’s what they need.

2. Empathise – Above all, let them know you care, simply by saying so; “I’m here for you , I love you and I’m thinking of you.” Think of useful things you can do, such as giving them a healthy meal so they don’t have to cook, rather than bland offers of “Let me know if there’s anything I can do to help.”

3. Take your lead from them – everyone reacts differently to a breast cancer diagnosis – the right way for them will be how they react. If they want to talk about – listen. If they don’t want to talk about it – let them know that’s fine and that if they ever do -you’re there to listen. Sometimes we just want a dose of normality!

Under no circumstances, talk about your neighbour, cousin, other friend – who had breast cancer and is now sky diving or whatever. Or use someone else or something you’ve read to tell them they’re going to be ok.

Above all – be there and listen.

Royal Marsden Breast Cancer Meeting

Frontier’s Dr Chris Lee joined the 18th Annual Royal Marsden Breast Cancer Meeting on 3rd October last week, at the Royal College of Physicians, London. The meeting, which brings together leading experts in breast cancer care, amongst other topics, focused on Supportive care and survivorship – specifically looking at Managing treatment side effects (Dr Matthew Brown) and Surgical options for lymphoedema (Mr. Kelvin Ramsey).

Dr Lee explained, “What came out in our discussions, was the critical importance of embedding quality-of-life interventions at the same time as oncological treatment; such as;

  • Early recognition and management with compression, skincare and exercise
  • Manual Lymphatic drainage and physiotherapy
  • Surgical options”.

Interestingly, Dr Oreste Gentilini (Milan) during the keynote, looked at reducing unnecessary axillary interventions such as lymph node removal, which would avoid patients risking the development of complications such as lymphoedema in the first place. Dr Gentilini reviewed several clinical trials ,which seemed to confirm that axillary clearance or lymph node removal, and even sentinel node biopsies, might be safely avoided.

In the Oncology update, Professor Nick Turner and Dr Michael Hubank explored how precision molecular testing has become part of routine care, effectively tailoring treatments to tumour biology.

Dr Lee summarised, “It was a good mix of practical guidance, cutting-edge science and at times, quite thoughtful debate!”

Looking forward to October Breast Cancer Awareness – Check yourself

✨ DON’T FORGET TO CHECK YOURSELF ✨

If you’re lucky and haven’t been diagnosed with breast cancer – or if you’ve been through it and come out the other side – it’s still so important to keep an eye on your breast health.

But here’s the good news: there’s no strict technique you need to learn. Our experts (and guidelines worldwide) now reassure us that you don’t need to follow a complicated monthly “self-exam.” What matters most is simply getting to know what’s normal for you so that you notice when something change

SO, HOW DO YOU DO IT?

– There’s no single “correct” way. You might choose a moment that works for you – in the shower, while getting dressed, or even relaxing in the bath.
– The key is to notice your normal – the look and feel of your breasts.
– That way, if something changes, you will pick it up more quickly.

💡 Tip: Some people find it helpful to schedule a monthly reminder on their phone, just to build the habit.

WHAT CHANGES SHOULD I LOOK OUT FOR?

Even if you check regularly, not every lump will be easy to feel – sometimes tumours are hidden. That’s why it’s important to look out for a range of possible clues, including:

– A new lump or thickening in the breast or armpit
– A change in size, shape, or feel of the breast
– Skin changes (dimpling, puckering, redness, rash, or an “orange peel” texture)
– Nipple changes (turning in, new discharge, or bleeding)
– Persistent pain in one spot

If you notice any of these changes, book an appointment with your GP promptly. Most changes won’t be cancer, but it is always better to be safe.

BREAST AWARENESS – SIMPLE CODES TO REMEMBER

The UK’s Five-Point Code

  1. Know what is normal for you
    2. Know what changes to look for
    3. Look and feel
    4. Report changes promptly
    5. Attend screening when invited

The AUK Initiative (Awareness, Understanding, Knowledge)

– Awareness → Be alert to your breast health
– Understanding → Know the signs and symptoms
– Knowledge → Feel confident to act quickly and attend screening

The Take-Home Message

🩷 You don’t need a strict exam routine.
🩷 You do need to know what feels right for your body.
🩷 If something changes, act quickly and see your GP.
🩷 And keep up with mammograms when you’re invited – they remain the best tool for early detection.

Early detection saves lives – so this October, make time for yourself.